Dessolin, Jean <br/><br/>
N-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexahydro-cyclopenta[e][1,3]oxazin-4-yl)-phenyl)-amides as BACE1 inhibitors: a patent evaluation of WO2013041499.  [electronic resource] 

 -  Expert opinion on therapeutic patents  Feb 2014 
 - 239-42 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7674 
<br/><br/><label>Standard No.: </label>10.1517/13543776.2014.859246  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Disease--drug therapy<br/>Amides--chemistry<br/>Amyloid Precursor Protein Secretases--antagonists & inhibitors<br/>Amyloid beta-Protein Precursor--metabolism<br/>Animals<br/>Aspartic Acid Endopeptidases--antagonists & inhibitors<br/>Drug Design<br/>Drug and Narcotic Control<br/>Humans<br/>Molecular Structure<br/>Molecular Targeted Therapy<br/>Oxazines--chemistry<br/>Patents as Topic<br/>Protease Inhibitors--chemistry<br/>Structure-Activity Relationship